On March 2, 2023, ZYUS Life Sciences Corporation closed the transaction. The company has received $18,557. The transaction included participation from a single investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 CAD | -4.55% | -2.78% | +16.67% |
05-07 | ZYUS Life Sciences Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04-23 | ZYUS Life Sciences Receives US Patent for Pain Management Drug Candidate | MT |
1st Jan change | Capi. | |
---|---|---|
+16.67% | 57.11M | |
+64.23% | 55.07B | |
-2.31% | 41.79B | |
+44.36% | 40.22B | |
-8.29% | 28.17B | |
+11.97% | 26.28B | |
-21.16% | 18.93B | |
+7.54% | 13.03B | |
+27.17% | 12.26B | |
+25.72% | 12.21B |
- Stock Market
- Equities
- ZYUS Stock
- News ZYUS Life Sciences Corporation
- ZYUS Life Sciences Corporation announced that it has received $0.018557 million in funding